Unlike most other cutaneous neoplasms, extramammary Paget disease (EMPD) manifests as a chronic erythematous patch. In this resident takeover, Dr. Daniel Mazori talks to Dr. Mohammed Dany about the diagnosis of primary vs secondary EMPD and the importance of screening patients for metastasis or other underlying malignancies. They also discuss the pathogenesis of EMPD and highlight future treatment targets. “The best studies that show potential are the studies focusing on PD-1 [programmed cell death receptor 1] pathway, or the checkpoint pathway. I think there is a lot of potential with immunot ..read more

To celebrate the 50th anniversary of Dermatology News, we are looking back at how the field has changed since that first issue in January 1970. The focus in episode 73 is infectious disease. There’s a lot to be grateful for but there are also challenges like antibiotic resistance that weren’t on the radar of dermatologists decades ago. In this episode, Nick Andrews welcomes Theodore Rosen, MD, to discuss the past, future, and current state of ID Dermatology. You can read more about the past 50 years of ID by clicking this link: https://bit.ly/3hri3v2 You can learn more about Dr. Rosen by click ..read more

In the news portion of episode 64, Nick Andrews welcome Dr. Amy Paller, MD, to discuss the different dermatologic manifestations of COVID-19 especially as it pertains to pediatric patients. *  *  * Grand Rounds are not only a teaching opportunity but also a vital patient care activity. Dr. Vincent DeLeo talks to Dr. William Huang about results of a study that surveyed how patients perceive clinical case-viewing sessions in dermatology. “I think we can easily lose track of [the patient’s experience] because it is something very routine for us as an activity that we have participated i ..read more

Unlike most other cutaneous neoplasms, extramammary Paget disease (EMPD) manifests as a chronic erythematous patch. In this resident takeover, Dr. Daniel Mazori talks to Dr. Mohammed Dany about the diagnosis of primary vs secondary EMPD and the importance of screening patients for metastasis or other underlying malignancies. They also discuss the pathogenesis of EMPD and highlight future treatment targets. “The best studies that show potential are the studies focusing on PD-1 [programmed cell death receptor 1] pathway, or the checkpoint pathway. I think there is a lot of potential with immunot ..read more

To celebrate the 50th anniversary of Dermatology News, we are looking back at how the field has changed since that first issue in January 1970. The focus in episode 73 is infectious disease. There’s a lot to be grateful for but there are also challenges like antibiotic resistance that weren’t on the radar of dermatologists decades ago. In this episode, Nick Andrews welcomes Theodore Rosen, MD, to discuss the past, future, and current state of ID Dermatology. You can read more about the past 50 years of ID by clicking this link: https://bit.ly/3hri3v2 You can learn more about Dr. Rosen by click ..read more

In the news portion of episode 64, Nick Andrews welcome Dr. Amy Paller, MD, to discuss the different dermatologic manifestations of COVID-19 especially as it pertains to pediatric patients. *  *  * Grand Rounds are not only a teaching opportunity but also a vital patient care activity. Dr. Vincent DeLeo talks to Dr. William Huang about results of a study that surveyed how patients perceive clinical case-viewing sessions in dermatology. “I think we can easily lose track of [the patient’s experience] because it is something very routine for us as an activity that we have participated i ..read more

Recent studies have highlighted poor representation of darker skin types in dermatology textbooks and online resources. Vincent A. DeLeo, MD, talks to Jules B. Lipoff, MD (@juleslipoff), about the general paucity of images of skin of color in learning resources as well as an overrepresentation of darker skin types in material about sexually transmitted infections. “We should be teaching our students and our residents. It shouldn’t be just a skin of color lecture. Skin of color should through every lecture. We should be showing how everything presents in every skin type,” Dr. Lipoff notes. They ..read more

In 2019, the two CPT codes for skin biopsies were replaced with sex new codes that specify biopsy technique and associated procedural complexity. Vincent A. DeLeo, MD, talks to medical student Sheena Desai and Rebecca I. Hartman, MD, MPH, about this CPT change and its effect on the frequency of shave versus punch biopsies in both private and academic practices. “The average dermatologist needs to be cognizant of the fact that changing reimbursements may hypothetically influence [the] provider’s decision on what biopsy type to perform,” Ms. Desai notes. They also explain how this data can be ex ..read more

COVID-19 affects multiple organ systems, and skin manifestations are prevalent. Dr. Vincent DeLeo talks to medical student Lauren Schwartzberg and Ann Lin, DO, about both common and rare cutaneous presentations of COVID-19. “I think it’s important to look at the unexplained rashes a little differently now than ever before the COVID era ... a thorough history of COVID-19 exposures and perhaps even COVID-19 testing should be considered,” Ms. Schwartzberg notes. They also discuss differences in presentation seen in adult and pediatric patients. Article: https://www.mdedge.com/dermatology/article ..read more

Recent surveys show that dermatologic examinations tend to neglect the genital area. In this resident takeover, Sophie A. Greenberg, MD (@sophiegreenberg), talks to Margaret Maria Cocks, MD, PhD (@Margaret_Cocks), about the lack of focus on the genital area in the total-body skin examination (TBSE), especially in female patients, and the paucity of training on genital examinations in residency. “While [melanoma] is rare, a lot of the time when genital melanomas are identified, they’re often found later and more aggressive stages ... partially that might be because this area is not routinely ex ..read more